Does NIVOLUMAB Cause Dermatitis atopic? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Dermatitis atopic have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
5
Reports of Dermatitis atopic with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Dermatitis atopic From NIVOLUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Dermatitis atopic Listed in the Official Label?
Yes, Dermatitis atopic is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
Which NIVOLUMAB Alternatives Have Lower Dermatitis atopic Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE